Results 161 to 170 of about 121,794,009 (205)
Anatomical Proposal for Botulinum Neurotoxin Injection Targeting the Platysma Muscle for Treating Platysmal Band and Jawline Lifting: A Review [PDF]
The platysma muscle is a thin superficial muscle that covers the entire neck and lower part of the face. The platysma muscle is the primary target muscle for botulinum neurotoxin injection therapy aimed at treating platysmal band and lower facial lifting.
Kyu-Ho Yi, Kang-Woo Lee, Hee-Jin Kim
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Botulinum Neurotoxin Type A Injections for Vaginismus Secondary to Vulvar Vestibulitis Syndrome
Obstetrics & Gynecology, 2009To investigate whether botulinum neurotoxin type A improves vaginismus and study its efficacy with repeated treatments.Outpatients were referred because standard cognitive-behavioral and medical treatment for vaginismus and vulvar vestibular syndrome failed.
Laura, Bertolasi +5 more
openaire +2 more sources
Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg
Muscle & Nerve, 2009AbstractBotulinum neurotoxin type‐A (BoNT/A) is very effective in the therapy of a wide range of human syndromes characterized by hyperactivity of peripheral cholinergic nerve terminals. Little diffusion of this toxin from the site of injection is commonly observed, but even minor changes in this property would greatly affect the validity of the ...
CARLI L +2 more
openaire +2 more sources
Aesthetic Plastic Surgery, 2022
This study was conducted to see if better scar results could be obtained by administering botulinum neurotoxin type A (BoNTA) injection and W-plasty incision for preventing rhytidectomy scar.All patients underwent extended deep-plane rhytidectomy in two groups. Group 1 had a straight incision line, and BoNTA was not given.
openaire +2 more sources
This study was conducted to see if better scar results could be obtained by administering botulinum neurotoxin type A (BoNTA) injection and W-plasty incision for preventing rhytidectomy scar.All patients underwent extended deep-plane rhytidectomy in two groups. Group 1 had a straight incision line, and BoNTA was not given.
openaire +2 more sources
Paradoxical masseteric bulging after botulinum neurotoxin type A injection
BMJ Case ReportsParadoxical masseteric bulging refers to an unexpected occurrence of masseter muscle bulging or protrusion following the administration of botulinum toxin injections, contrary to the anticipated muscle weakening effect. It may occur secondary to toxin failing to diffuse through the entire masseter muscle due to the presence of an inferior tendon ...
Shaiba Sandhu, Jeffry Shaefer
openaire +2 more sources
Rare and novel complications of botulinum neurotoxin type A and dermal filler injections
Clinics in DermatologyBotulinum neurotoxin type A (BoNTA) and filler injection procedures usually provide predicted outcomes with a low incidence of complications. Most of the complications after these procedures have been extensively discussed. In this study, we report on these injectables' less well-known, recently reported, and novel complications and attempt to clarify ...
Marina, Landau +3 more
openaire +2 more sources
Clean Intermittent Self-Catheterization After Botulinum Neurotoxin Type A Injections
Obstetrics & Gynecology, 2009To investigate the hypothesis that the need for clean intermittent self-catheterization after botulinum neurotoxin type A injections is outweighed by the efficacy of this treatment, so that clean intermittent self-catheterization is not a burden for patients with refractory idiopathic detrusor overactivity.Women undergoing intradetrusor injections of ...
Kessler, Thomas M. +5 more
openaire +3 more sources
European Urology, 2008
Limited studies to date have reported on the onset of effect of intradetrusor botulinum neurotoxin type A (BoNTA) injections when used to treat the symptoms of the overactive bladder (OAB). Furthermore, few studies have examined the effect of BoNTA on urgency and nocturia, now recognised as the most bothersome symptoms of the OAB syndrome.
Kalsi, Vinay +5 more
openaire +4 more sources
Limited studies to date have reported on the onset of effect of intradetrusor botulinum neurotoxin type A (BoNTA) injections when used to treat the symptoms of the overactive bladder (OAB). Furthermore, few studies have examined the effect of BoNTA on urgency and nocturia, now recognised as the most bothersome symptoms of the OAB syndrome.
Kalsi, Vinay +5 more
openaire +4 more sources
Toxicology and Applied Pharmacology, 1986
To determine the efficacy of 3,4-diaminopyridine (3,4-DAP) as a potential treatment for botulism, its effect on the survival times of mice injected with type A, B, E, or F botulinum toxin (Bo Tx) was examined. Mice were injected ip with 10, 20, or 40 LD50 of Bo Tx. Three hours later, when the mice displayed signs of botulism, half of each group of mice
L S, Siegel +2 more
openaire +2 more sources
To determine the efficacy of 3,4-diaminopyridine (3,4-DAP) as a potential treatment for botulism, its effect on the survival times of mice injected with type A, B, E, or F botulinum toxin (Bo Tx) was examined. Mice were injected ip with 10, 20, or 40 LD50 of Bo Tx. Three hours later, when the mice displayed signs of botulism, half of each group of mice
L S, Siegel +2 more
openaire +2 more sources
European Urology, 2009
Previous studies in humans, dogs, and rats have shown that intraprostatic injection of botulinum neurotoxin type A (BoNTA) reduces gland size.To investigate the role of eventual impairment of sympathetic, parasympathetic, and sensory nerves to gland atrophy after intraprostatic BoNTA administration.Adult male Wistar rats weighing 300-350 g were used ...
João, Silva +6 more
openaire +2 more sources
Previous studies in humans, dogs, and rats have shown that intraprostatic injection of botulinum neurotoxin type A (BoNTA) reduces gland size.To investigate the role of eventual impairment of sympathetic, parasympathetic, and sensory nerves to gland atrophy after intraprostatic BoNTA administration.Adult male Wistar rats weighing 300-350 g were used ...
João, Silva +6 more
openaire +2 more sources

